Conditions: Glaucoma Ocular Hypertension Open-angle Glaucoma
Keywords: Glaucoma Ocular hypertension Intraocular pressure (IOP) Open angle glaucoma Pigment dispersion glaucoma Pigmentary
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 57
Healthy volunteers: no

Brief summary:
The purpose of this study was to assess the efficacy and tolerability of changing to AZARGA® from prior brimonidine 0.2%/timolol 0.5% fixed combination (COMBIGAN®) therapy in patients with open-angle glaucoma or ocular hypertension and uncontrolled intraocular pressure (IOP).

Detailed description:

Arms:
arm 1: Brinzolamide 1% / timolol 0.5% maleate fixed combination, 1 drop self-administered in study eye(s) twice daily for 8 weeks (8AM and 8PM)

Interventions: intervention 1: Brinzolamide 1% / timolol 0.5% maleate fixed combination
Intervention descriptions: intervention 1: None

Protocol document: